Biomolecular MRI reporters: Evolution of new mechanisms by Mukherjee, Arnab et al.
Biomolecular MRI Reporters: evolution of new mechanisms
Arnab Mukherjee1, Hunter C. Davis1, Pradeep Ramesh2, George J. Lu1, and Mikhail G. 
Shapiro1
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, 
CA 91125, USA
2Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 
91125, USA
Abstract
Magnetic resonance imaging (MRI) is a powerful technique for observing the function of specific 
cells and molecules inside living organisms. However, compared to optical microscopy, in which 
fluorescent protein reporters are available to visualize hundreds of cellular functions ranging from 
gene expression and chemical signaling to biomechanics, to date relatively few such reporters are 
available for MRI. Efforts to develop MRI-detectable biomolecules have mainly focused on 
proteins containing or transporting paramagnetic metals for T1 and T2 relaxation enhancement or 
large numbers of exchangeable protons for chemical exchange saturation transfer. While these 
pioneering developments established several key uses of biomolecular MRI, such as imaging of 
gene expression and functional biosensing, they also revealed that low molecular sensitivity poses 
a major challenge for broader adoption in biology and medicine. Recently, new classes of 
biomolecular reporters have been developed based on alternative contrast mechanisms, including 
enhancement of spin diffusivity, interactions with hyperpolarized nuclei, and modulation of blood 
flow. These novel reporters promise to improve sensitivity and enable new forms of multiplexed 
and functional imaging.
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1. Introduction
The ability to image the function of specific cells and molecules within the context of living 
mammalian organisms is critical for basic biological studies and the development of cellular 
and genetic therapeutics. Magnetic resonance imaging (MRI) is ideally suited to provide this 
capability due to its ability to image whole organs and animals non-invasively with high 
spatial and temporal resolution. However, unlike optical imaging, which has access to a 
multitude of biomolecular reporters to visualize specific aspects of cellular function, MRI is 
still in its infancy with regard to its repertoire of biomolecular tools. Over the past 20 years, 
efforts to develop such tools have primarily focused on biomolecules embodying the 
properties of synthetic contrast agents, such as paramagnetic ions, superparamagnetic 
nanoparticles, and chemical exchange substrates, or on causing the accumulation of these 
synthetic agents in cells, thereby altering the magnetic resonance signal of water protons or 
other nuclei in their vicinity. These biomolecular reporters have enabled the visualization of 
previously invisible processes using MRI, such as gene expression, cell migration, and 
neurotransmission. In addition, they have enabled the use of advanced protein engineering 
techniques, including directed evolution, to develop dynamic sensors capable of transducing 
time-varying biochemical signals into MRI contrast changes for real-time functional 
imaging. Despite these advances, the broader adoption of these technologies by the 
biomedical community has been hindered by important limitations of these reporters, 
including their relatively low molecular sensitivity and requirement of metal or synthetic 
cofactors.
Recently, new biomolecular contrast mechanisms have been introduced that attempt to 
overcome these limitations, including proteins that act on hyperpolarized nuclei, alter water 
transport and modify hemodynamics. Notably, some of these new mechanisms are uniquely 
enabled by biomolecules; that is, they would be impossible or difficult to implement with 
synthetic agents. The goal of this review is to briefly describe the new classes of 
biomolecular reporters, place them within the quantitative context of existing contrast 
mechanisms, and provide an outlook for future developments.
2. Quantitative framework
A key focus of this review is the molecular sensitivity of biomolecular reporters, which we 
define as the minimal concentration of the reporter that must be present in a voxel to achieve 
an acceptable level of contrast. While this depends on several factors, including field 
strength, the overall signal-to-noise ratio (SNR) and the properties of background tissue, we 
will examine performance under “typical” conditions for conventional small animal 1H 
imaging – the primary arena for biomolecular reporter development. Given an SNR of 400 
(corresponding to a typical spin echo-based image acquisition sequence at 7 T with 10 
averages and an isotropic voxel size of 300 µm, adapted from [1]), a reporter would have to 
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increase or decrease the signal in a voxel by 1.25% to achieve a contrast-to-noise ratio 
(CNR) of 5 (i.e. 1.25% of 400). This CNR is sufficient to detect reporter-based contrast 
relative to tissue [2]. The minimal reporter concentration needed to achieve this CNR will 
serve as our basis for comparing the reporter classes described in the following sections and 
shown in Table 1. Given the wide range of molecular weights encompassed by biomolecular 
MRI reporters, as well as the inherent dependence of certain contrast mechanisms on 
molecular size, both molar and mass-based estimates are useful for reporter comparison. 
Hence, in addition to asking “how many molecules must a cell make” to produce visible 
contrast (in µM), we also ask “how much total protein mass must a cell make” for this 
purpose (in µg/mL). Calculations are further explained in the Appendix.
3. Established Mechanisms of Biomolecular MRI: T1, T2, CEST, 
Accumulation and Activation
We start by briefly describing the established classes of biomolecular MRI reporters as 
background for our discussion of new mechanisms. Interested readers may also consult 
several excellent reviews [3–8].
3.1. T1 Reporters
Biomolecular T1 agents are typically metalloproteins containing iron or manganese 
cofactors [9–11], which produce relaxation enhancement via a predominantly inner-sphere 
dipole-dipole mechanism, achieving relaxivity (rCA as defined in Eq. A4 and Table 3 of the 
Appendix) on the order of single mM−1 s−1 (Fig. 1a). In addition to acting as reporters, 
metalloproteins can be engineered as molecular sensors, wherein the binding of specific 
ligands occludes water coordination to the metal ion, resulting in reduced relaxivity. For 
example, the bacterial cytochrome P450-BM3 contains a heme-bound Fe(III) atom, which 
produces T1 contrast with a relaxivity of 1.4 mM−1 s−1 at 4.7 T. A catalytically-inactive 
version of this protein was engineered by Shapiro et al. using directed evolution to bind the 
neurotransmitter dopamine and thereby act as a sensor of this neurotransmitter [9]. This 
sensor and its derivatives have been applied to studying dopamine and serotonin release and 
reuptake in rodent brains [12, 13].
A significant limitation of existing biomolecular T1 reporters and sensors is their modest 
relaxivity, in the range of 1–2 mM−1 s−1. For a 1.25% change in signal in a T1-weighted 
image (with a background T1 of 1.5 s), ~ 14 µM concentration of the reporter (~ 700 µg/ml 
for a 50 kDa protein such as the dopamine sensor [9]) is needed to produce the required 0.01 
s−1 relaxation enhancement. This concentration may be difficult to achieve through 
heterologous expression, especially given the need to load the protein with metal ions and/or 
additional co-factors such as heme groups. Nevertheless, the ability to engineer these 
proteins as functional sensors has made them useful as injectable imaging agents that are 
expressed and purified separately.
Efforts to improve relaxivity have focused on identifying proteins with higher-spin metals, 
including Mn2+ [10], and exchanging natural metals with higher-spin alternatives including 
Mn2+ and Gd3+ [14, 15]. In theory, if appropriate proteins can be engineered, and issues 
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with metal bioavailability can be solved, the molecular sensitivity could improve, especially 
for imaging conducted at lower field strengths [16].
3.2. T2 Reporters
One of the first biomolecular MRI reporters to be used in mammals was ferritin, an iron 
storage protein that biomineralizes a ferrihydrite core with up to 4,500 iron atoms inside a 
12 nm diameter protein shell (Fig. 1b). The ferritin core is magnetic, allowing the protein to 
produce T2 or T2* contrast, although a theoretical understanding of this contrast mechanism 
is incomplete [17]. Since its development as a reporter, ferritin has been used in several 
studies to monitor cell migration or gene expression. In addition, ferritin-based sensors have 
been engineered to produce enhanced T2 relaxation in response to analytes such as protein 
kinase A through a clustering mechanism [18]. The quantitative sensitivity of ferritin 
depends on its loading level, which is typically ~ 2,500 iron atoms per particle, which 
provide a relaxivity at 7 T of 1.28 mM−1 s−1 in terms of iron or 3,000 mM−1 s−1 in terms of 
ferritin particles [19]. To produce a 1.25% signal change on top of a typical 50 ms tissue T2, 
a relaxation enhancement of ~ 0.25 s−1 requires a relatively low ferritin particle 
concentration of 84 nM and a protein mass of ~ 40 µg/mL (given a total molecular weight of 
~ 480 kDa for ferritin). However, a significant challenge with T2 reporters is the specificity 
of their contrast, since multiple sources of magnetic susceptibility differences, such as blood 
and air compartments, exist inside tissues [20, 21]. These can confound the assignment of 
hypointense regions on T2 images. Signal changes significantly larger than 1.25%, and 
concomitantly higher concentrations of ferritin, may therefore be required to confidently 
locate the reporter in certain tissues. This may be challenging, since even 84 nM ferritin 
already represents an iron concentration of ~ 210 µM, which may not be achievable in all 
tissues. Additionally, the relaxivity of ferritin and other magnetic materials in tissues has a 
strong dependence on their subcellular spatial arrangement [22].
Significant room for improvement exists in the sensitivity of biomolecular T2 reporters when 
they are compared to synthetic iron oxide nanoparticles and biogenic magnetite from 
magnetotactic bacteria, which have relaxivities on the order of 100 mM−1 s−1. Indeed, 
purified ferritin loaded with a superparamagnetic iron core in vitro under high temperature 
and alkaline pH, has a more than 100-fold stronger per-iron relaxivity compared to natural 
ferritin [23]. However, magnetite/maghemite mineralization in mammalian cells or bacteria, 
other than magnetotactic bacteria or their close relatives [24], has not been reported, and is 
challenging due to the strict chemical conditions required for such mineralization. Recent 
attempts to engineer or evolve ferritin have resulted in particles with somewhat stronger 
MRI contrast, but no evidence of minerals other than ferrihydrite [25–27]. Other 
biomolecular T2 reporters that may interest the reader include hemoglobin [28], tyrosinase 
[29], and mms6 [30].
3.3. Chemical Exchange Saturation Transfer (CEST) Reporters
Another pioneering form of biomolecular MRI, CEST imaging, takes advantage of the 
abundance of exchangeable protons on the protein backbone and amino acid side chains 
(Fig. 1c). By applying radiofrequency saturation at the chemical shift of these protons while 
they exchange with surrounding water, a fraction of the aqueous proton pool becomes 
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depolarized, thereby producing contrast. Although this exchange also takes place with 
endogenous proteins present in tissue, the overexpression of proteins containing large 
numbers of proton-exchangeable amino acids, such as lysine-rich protein or human 
protamine 1, can generate significant contrast above background [31–33]. Molecular 
sensitivity is further aided by the fact that each protein contains hundreds of exchangeable 
protons. An additional feature of biomolecular CEST reporters is their potential for 
multiplexed imaging, which can be accomplished using poly-amino acids (such as poly-
lysine and poly-arginine) that have exchangeable proton signals at specific chemical shifts 
[34].
The molecular sensitivity of CEST reporters is limited by the proton exchange rate, which 
must be slow compared to their chemical shift difference from water, Δω, for efficient 
saturation transfer [35–37], but faster than T1 or T2 relaxation. With a typical exchange rate 
on the order of 1 kHz, 200 exchangeable groups, and a saturation time comparable to T1, the 
1.25% signal change detection limit under ideal saturation conditions should be on the order 
of 2.5 µM (or ~ 80 µg/mL protein assuming a molecular weight of 32 kDa as for poly-lysine 
[33]). However, in in vivo applications, biomolecular CEST agents must also overcome 
background CEST contrast from endogenous proteins, making their detection at such low 
concentrations more difficult. Despite this limitation, protein-based CEST reporters have 
been used in several in vivo applications, and innovative pulse sequences and processing 
schemes have been developed to help maximize reporter-specific contrast [38–40].
3.4. Accumulation or Activation Reporters
In addition to biomolecular MRI reporters that act directly on nuclei, it is also possible to 
generate MRI contrast indirectly via biomolecules that locally trap or activate exogenous 
contrast agents (Fig. 1d). This mechanism represents a form of amplification because each 
biomolecular reporter can transport or chemically modify multiple contrast agents, each of 
which then interacts with nuclei. Indeed, the earliest examples of biomolecular reporters for 
magnetic resonance belong to this category. In 1990, Koretsky et al. showed that 
overexpression of creatine kinase led to accumulation of phosphocreatine, which could be 
detected with 31P NMR [41]. Another early example was beta galactosidase, which cleaves a 
sugar group from a specially designed Gd3+ chelate, thereby unblocking water accessibility 
and increasing T1 relaxivity [42]. Other reporters have been based on proteins that transport 
paramagnetic species such as Mn2+[11], gadolinium chelates [43], transferrin [44, 45] or 
ferritin [46] into cells or trap small molecule CEST reporters [47]. Alternatively, proteins 
have been engineered to display biotin on the cell surface, allowing binding and 
accumulation of an inorganic imaging agent linked to a biotin-binding protein such as 
streptavidin or transferrin [48, 49].
Since each protein potentially leads to accumulation of many contrast-generating molecules, 
reporters acting through amplified mechanisms can reach a high level of molecular 
sensitivity, and are therefore likely to find many uses. Their key limitations reflect the need 
to administer an exogenous agent prior to read-out, with concomitant pharmacokinetics and 
toxicity profiles, and the potential difficulty of interpreting quantitatively the resulting 
contrast with regard to biomolecule concentration. In addition, amplification introduces 
Mukherjee et al. Page 5
Prog Nucl Magn Reson Spectrosc. Author manuscript; available in PMC 2018 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
substrate accumulation or activation kinetics into the temporal performance of these 
reporters, making it more difficult to engineer them as dynamic sensors.
4. Emerging Mechanisms of Biomolecular MRI: Diffusion, 
Hyperpolarization, and Hemodynamics
4.1. Diffusion based Reporters
One of the newest additions to biomolecular MRI is the use of water-permeable membrane 
channels as reporter genes for diffusion weighted imaging (DWI) (Fig. 1e). DWI is a widely-
used technique in anatomical imaging, in which diffusion weighting is commonly achieved 
by applying a pair of pulsed magnetic field gradients, which dephase nuclear spins in 
proportion to how far they diffuse during a defined period [50–52]. Accordingly, water 
molecules that diffuse more freely have more severely dephased proton spins and appear 
darker in DWI. In biological tissues, the effective diffusivity of water depends on multiple 
parameters, including the local diffusivity in intracellular and extracellular compartments, 
the relative volume fraction occupied by cells, and the exchange rate of water across the 
plasma membrane [53–55].
In light of the importance of transmembrane diffusion, it was recently proposed that 
facilitating water exchange across the membrane by overexpressing water-permeable 
channels would result in enhanced contrast in DWI or more specialized sequences [56, 57]. 
The most natural class of molecules for achieving this goal is aquaporins, a highly conserved 
family of tetrameric integral membrane proteins that mediate the selective exchange of water 
molecules across the plasma membrane in a wide range of cell types [58–63]. In 2016, 
Mukherjee et al. demonstrated that mammalian cells engineered to overexpress the human 
gene aquaporin 1 (AQP1) using lentiviral vectors could be visualized by DWI in vitro and in 
tumor xenografts in mice (Fig. 2a, b). Strikingly, expression in cultured cells at 
concentrations as low as 500 nM (or 14 µg/mL for the 28 kDa aquaporin protein) resulted in 
changes in the apparent diffusion coefficient (ADC) of 50% [56].
Making aquaporin work as a sensitive reporter gene required the use of a stimulated echo 
DWI sequence rather than standard spin echo DWI [53, 64]. This is because longer 
timescales are needed for water molecules to encounter membranes as a diffusion barrier 
(Fig. 2c). The key pulse sequence parameter driving this interaction is known as Δ, which 
needs to be 100 ms or longer to produce pronounced aquaporin-dependent contrast, whereas 
in typical DWI, Δ ~ 10 ms. This dependence was examined in detail via Monte Carlo 
simulations and experiments (Fig. 2c). At Δ = 398 ms, an ADC change of more than 180% 
was measured in cells expressing AQP1 under a strong inducible promoter (Fig. 2d). 
Another parameter potentially affecting this contrast mechanism concerns the fraction of 
cells in a tissue that overexpresses aquaporin. For instance, one might imagine that a highly 
permeable cell surrounded by impermeable cells would have negligible influence on overall 
diffusivity. Interestingly, simulations and experiments both showed that while a non-linear 
relationship indeed exists between expressing fraction and overall contrast, sub-populations 
as small at 10% can be visualized. Based on their high sensitivity and functionality in mixed 
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populations, aquaporins should be useful for genetically labeling cell-based therapeutics to 
track them in the context of animal models and potentially in human patients.
Aquaporin overexpression is non-toxic, as shown in three cell lines and tumor xenografts 
engineered to overexpress aquaporins [56]. This is not surprising, since aquaporins such as 
AQP1 are highly selective for water, which they simply allow to diffuse back and forth 
across the cell membrane under the osmotically balanced conditions existing in all but a few 
body organs. Two further advantages of this class of reporter genes are that it requires no 
metals or exogenously administered contrast agents and can be autologous to the host 
species, reducing concerns about reporter immunogenicity. In addition, aquaporin produces 
contrast orthogonal to paramagnetic and CEST reporters, potentially allowing multiplexing. 
Furthermore, the wide variety of aquaporin genes present across all domains of life opens 
the door to engineering improved and potentially functional biomolecular reporters.
One limitation of aquaporin as a reporter gene is the variation in endogenous water 
diffusivity across tissue types, driven by factors such as cell size and density, as well as 
native expression of aquaporins. Tissues with inherently low water diffusivity are the most 
suitable for imaging with aquaporins, provided that the aquaporin reporter gene can be 
delivered and expressed in the tissue using established approaches for gene delivery such as 
viral vectors. For instance, tumors, with their dense cellularity and low background 
diffusion, are ideal tissues to express aquaporin reporters to image gene expression in 
preclinical animal models, while the brain, with its comparatively lower cellularity and 
inherently high aquaporin expression in glia, has a more diffusive background making the 
detection of aquaporin overexpression more challenging. These issues may be partially 
addressed with pulse sequence development; for example, acquiring DWI images at multiple 
values of Δ would help distinguish contrast based on cell permeability from contrast based 
on morphology. In addition, animal models involving genetic knockdown of endogenous 
aquaporins [62, 63] may be used to reduce native aquaporin expression to generate local 
contrast in high-expressing tissues.
In addition to aquaporin, a separate study recently reported that the urea transporter (UT-B) 
could also be used as a reporter gene based on its ability to increase the permeability of cell 
membranes [57]. In addition to urea, UT-B is able to transport water at rates similar to 
aquaporin. UT-B expression was visualized using a filter-exchange imaging (FEXI) 
sequence, in which a pulsed gradient is first used to dephase fast-diffusing extracellular 
water, then a variable time is given for exchange of water from this compartment with the 
slower-diffusing cytoplasmic water, after which a second diffusion-weighting is applied to 
measure the apparent diffusivity. Membrane permeability results in faster exchange between 
the compartments, allowing the ADC to return to equilibrium more quickly. Using this 
sequence, the apparent exchange rate between the two compartments increased by up to ~ 
100% with UT-B expression in vitro, and it was possible to image gene expression in vivo. 
Notably, no significant changes in ADC were measured in cells expressing UT-B, which is 
likely due to the study’s use of a spin echo DWI sequence with a short Δ.
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4.2. Reporters for hyperpolarized MRI
Among the recent breakthroughs in molecular MRI is hyperpolarization - the preparation of 
nuclear spins in nonequilibrium states of high magnetization. This technology directly 
addresses the relatively low sensitivity of MRI, which is fundamentally due to the weakness 
of the interaction of nuclear spins with the applied magnetic field relative to Boltzmann 
energy. Hyperpolarization can be performed via several methods, including dynamic nuclear 
polarization (DNP) [65, 66], symmetry-breaking chemical reactions with parahydrogen [67–
69], and gas phase collisional spin exchange with optically excited alkalis [70–72], resulting, 
in the most favorable cases, in polarization increases on the order of 10,000-fold compared 
to thermal equilibrium [73, 74]. Molecules hyperpolarized using these methods can then be 
introduced into in vitro specimens and in vivo organisms, where their nonequilibrium 
polarization has a lifetime governed by T1 [75–78]. Importantly, because of the much higher 
net magnetization, imaging can be performed at much lower nucleus concentrations. 
Hyperpolarized organic compounds, such as 13C-pyruvate and fumarate, are typically 
imaged in a single shot following injection into the body, revealing their transport and 
metabolism [79] (using chemical shift imaging), which can provide clinically valuable 
information about diseases such as cancer [76, 80] and renal disorders [77]. Similarly, 
hyperpolarized noble gases such as 129Xe can be delivered into the body repeatedly via 
inhalation, producing gas-phase contrast in the lungs and solution-phase contrast in perfused 
tissues.
The increased average signal of hyperpolarized nuclei naturally motivates the development 
of contrast agents acting on molecules containing such nuclei (Fig. 1f). In particular, the 
biocompatibility and renewable (via inhalation) magnetization of 129Xe, has made it an 
attractive target for contrast agent development. In 2006, a seminal study by Schröder et al. 
[81] showed that organic compounds designed to bind xenon and alter its chemical shift 
could produce MRI contrast at nanomolar concentrations using the hyperpolarized analog of 
CEST, named HyperCEST. In this technique, saturation is applied at the chemical shift of 
xenon in the chemical host, which is then transferred to aqueous xenon via chemical 
exchange. In addition to the strong, hyperpolarized starting signal, this technique benefits 
from the high specificity of the host-bound xenon’s chemical shift and its large separation (~ 
100 ppm) from the aqueous peak. Several groups have developed innovative reporters and 
sensors based on Xe-binding hosts [82–86].
Initially, the prospect of developing analogous biomolecular HyperCEST reporters was 
considered remote due to the weak and short-lived interaction of xenon with most proteins 
[87–91]. However, in 2014 a study by Shapiro et al. showed that an unusual class of gas-
filled protein nanostructures called gas vesicles (GVs) could interact with hyperpolarized 
xenon so as to produce HyperCEST contrast at picomolar concentrations [92]. GVs, which 
evolved in photosynthetic microbes as a means to regulate buoyancy, comprise hollow gas 
compartments with dimensions on the order of 250 nm, enclosed by a 2 nm-thick protein 
shell, which is permeable to gas but excludes liquid water [93, 94] (Fig. 3, a–b). The study 
showed that GVs can interact with xenon to produce HyperCEST contrast with peak 
saturation approximately 175 ppm upfield from dissolved 129Xe (Fig. 3, c–d). The large 
chemical shift separation enables the contrast to be extremely efficient, with a GV detection 
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limit in the picomolar range (Fig. 3e), orders of magnitude lower than comparable proton 
contrast agents. Furthermore, GVs formed by different species of bacteria and archaea, in 
which these nanostructures differ in size and shape, produce HyperCEST saturation at 
different chemical shifts, thereby enabling multiplexed imaging. GVs have been shown to 
produce contrast as antibody-functionalized markers of cancer cells and as reporters of gene 
expression in E. coli.
The development of GVs as biomolecular reporters for HyperCEST leads to several 
interesting avenues for further investigation. For example, it will be interesting to study how 
the chemical shift observed for different types of particles relates to their genetically 
encoded properties, including size, shape, clustering state and the amino acid composition of 
their shell. Also important are the quantitative parameters defining the efficiency of 
HyperCEST contrast, including the binding capacity of GVs for xenon and the rate of 
exchange with surrounding media, which can be studied using the quantitative HyperCEST 
methodology developed by Kunth et al. [95]. This will enable the development of optimal 
radiofrequency saturation parameters for the specific exchange rate of GVs, and open the 
door to further engineering at the molecular level.
In addition to GVs, other biological structures may be able to serve as HyperCEST agents. 
For example, bacterial spores, a dormant cellular state comprising a multi-layered structure 
of ~ 1.5 µm size, were recently demonstrated for HyperCEST at a chemical shift 4.5 ppm 
downfield from aqueous xenon [84]. In addition, using strong saturation to compensate for 
fast exchange, it is possible to perform HyperCEST based on chemical exchange between 
free xenon in solution and xenon bound to the small protein, beta-lactamase [85].
Besides 129Xe, other hyperpolarized molecules that have been paired with biomolecular 
reporters including 13C labeled molecules such as N-acetyl-L-methionine (paired with 
aminoacylase) [96], 3,5-difluorobenzyl-L-glutamic acid (paired with carboxypeptidase G2) 
[97], pyruvate (paired with pyruvate decarboxylase) [98], urea (DWI with urea transporter 
UT-B) [99], and 19F labeled substrates that interact with bovine trypsin [100].
Ultimately, the effectiveness of hyperpolarized reporters in vivo depends on the ability of 
their cognate nuclei to reach target tissues while retaining significant polarization. In the 
case of 129Xe, its solubility (Ostwald coefficient 0.14) and T1 half-life (~ 10 s) suggest that 
the concentration of hyperpolarized xenon in a vascularized tissue such as the brain in mice 
will be on the order of 100 µM (assuming breathing of a 50% mixture of half-polarized, 
isotopically enriched 129Xe). At this concentration, and correcting for the longer effective T1 
time of polarization replenishment by inhalation, SNR is expected to be ~ 1% that of proton 
MRI, reducing overall spatial resolution. However, the molecular sensitivity will be sub-
nanomolar. Assuming the need to saturate 66% of the signal over a timescale of T1, an 
exchange rate of 10 kHz and an occupancy of 1,000 xenon atoms per GV, this results in a 
detection limit of ~ 10 pM particles or 4 µg/mL protein. Translating HyperCEST to in vivo 
applications is a major focus of ongoing research.
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4.3. Reporters modulating hemodynamics
Another recently introduced mechanism for biomolecular MRI involves peptides that act on 
smooth muscle cells to increase blood flow locally, resulting in blood oxygenation level 
dependent (BOLD) contrast [101] (Fig. 1g). Blood perfusion is naturally modulated in 
tissues based on metabolic demand via signaling molecules such as nitric oxide, and 
peptides such as the calcitonin gene related peptide (CGRP) [102, 103]. It was shown 
recently that local injection or cellular secretion of CGRP could elicit changes in BOLD 
contrast. Impressively, ~ 10 nM concentrations of this molecule were sufficient to produce 
this effect. CGRP can be considered a new kind of amplified reporter. Rather than acting 
directly on nuclear spins, it elicits a local change in the concentration of a paramagnetic 
contrast agent, in this case deoxyhemoglobin. However, unlike most other amplified 
reporters, no external administration of contrast agents is required, and kinetics can be rapid, 
since the blood flow can increase and decrease on a second timescale in response to 
appropriate signals. Furthermore, CGRP can be engineered as a molecular sensor, for 
example by incorporating autoinhibitory domains that become cleaved by proteases [101].
One potential limitation of hemodynamics-based reporters is the presence of active, 
fluctuating background signal in tissues such as the brain. However, this can be 
distinguished from reporter-induced signal by its kinetics or by inhibition of the background 
signaling. The potential effects of such inhibition, or of repeated or prolonged release of 
CGRP on physiology, also merit further study as this technology moves to broader adoption.
5. Outlook
The development of new classes of biomolecules that produce MRI contrast, such as water 
channels, vasomodulatory peptides, and gas vesicles is a significant step forward in 
expanding the capabilities of biomolecular MRI beyond the realm of conventional contrast 
mechanisms. Moving ahead, additional breakthroughs are possible through the discovery or 
engineering of biomolecules that leverage other emerging contrast mechanisms, which have 
thus far been limited to synthetic implementations. Notable examples include paramagnetic 
CEST (paraCEST) agents, parahydrogen-induced hyperpolarized molecules, and magnetic 
resonance energy transfer (MRET) -based sensors.
ParaCEST imaging achieves enhanced CEST sensitivity through the use of paramagnetic 
ions to induce large chemical shifts (50–100 ppm) in the resonance frequency of 
exchangeable protons, thereby enabling highly selective saturation and faster proton 
exchange compared with conventional CEST [36, 104]. Bioavailable metals such as iron 
[105], cobalt [106], and nickel [107] are well suited for paraCEST, which suggests that 
naturally occurring Ni, Co, and Fe-based metalloproteins could be developed as paraCEST 
reporter genes. Another approach to boost the sensitivity of MRI is parahydrogen induced 
polarization (PHIP) [68, 69]. In this technique, hyperpolarization is spontaneously 
transferred from the singlet parahydrogen spin state of H2 gas to a suitable substrate via 
chemical hydrogenation or reversible exchange at a catalytic site to achieve ~ 800 to 5000-
fold gain in NMR signal for protons or heteronuclei (such as 13C, 15N, 19F) in the substrate 
molecule [67, 69]. Hyperpolarization transfer is typically achieved using solvent-phase 
catalysis with organometallic complexes, which has constrained the in vivo applicability of 
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parahydrogen-based molecular imaging owing to toxicity concerns [108]. The development 
of biomolecular catalysts for aqueous phase hydrogenation or exchange-based transfer to 
polarize bioactive molecules in water would greatly simplify the translation of this highly 
sensitive MRI approach to living animals.
In addition to reporters, there is a great need for molecular sensors to dynamically 
interrogate cellular function. From this standpoint, new reporter proteins such as aquaporins 
and gas vesicles could serve as the basis for developing biomolecular sensors by leveraging 
tools and principles of protein engineering and synthetic biology [109], as has been done 
with T1, T2 and CEST-based sensors [9, 18, 32]. In addition, a new mechanism for 
modulating MRI contrast, called MRET [110], may provide another avenue towards 
dynamic MRI sensors analogous to optical reporters based on Förster resonance energy 
transfer (FRET). In MRET, T1 relaxation is tuned by controlling the nanoscale separation 
between a paramagnetic T1 enhancer (such as a synthetic Gd-chelate) and a 
superparamagnetic quencher nanoparticle (such as iron oxide). Reducing the distance 
between the paramagnetic enhancer and the quencher narrows the spectral density of 
electron spin fluctuations, leading to inefficient paramagnetic relaxation and longer T1 times 
[110]. The implementation of this concept in biomolecular sensors depends on first 
achieving biomineralization of strongly magnetic materials in cells. Biomolecular 
mineralization of super-paramagnetic materials would also enable their application for 
magnetic particle imaging (MPI) imaging, which has the potential to achieve background-
free imaging with high sensitivity using direct detection of particle magnetization rather than 
water magnetic resonance [111, 112]. In summary, we envision that the evolution of future 
generations of sensitive biomolecular MRI reporters and cellular sensors will play a crucial 
role in expanding the scope of truly functional imaging in the context of living animals.
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Appendix
Calculations assume a background signal-to-noise ratio (SNR) of 400, adapted from [1], and 
yield the reporter concentration needed to achieve a contrast-to-noise ratio (CNR) of 5 by 
producing a 1.25% change in signal [2] (see Tables 2 and 3 for lists of the various symbols 
and assumed parameters).
Concentration of T1 contrast agent needed to achieve a CNR of 5
The evolution of longitudinal magnetization in a T1-weighted experiment can be described 
using the following equation [117]:
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(A1)
To achieve a CNR of 5, the T1 agent must enhance longitudinal magnetization by a factor of 
1.25% relative to the background signal:
(A2)
(A3)
The relaxation rate in the presence of a contrast agent can be expressed by the following 
equation:
(A4)
Substituting the value of R1,CA from Eq. (A4) in Eq. (A3), we arrive at the following 
expression for contrast agent concentration:
(A5)
To calculate the optimal TR, we use Eq. (A6), which evaluates the TR that maximizes signal 
relative to background:
(A6)
Eq. (A5) and (A6) can be solved numerically to evaluate xCA which is the minimum 
concentration of the T1 agent needed to produce a 1.25% signal enhancement using an 
optimized TR time.
Concentration of T2 contrast agent needed to achieve a CNR of 5
A similar approach can be used to calculate the minimum concentration of T2 agent required 
to produce a 1.25% decrease in signal relative to background. In this case, dephasing of 
transverse magnetization from spin-spin interactions is described by the following equation 
[117]:
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(A7)
To achieve a CNR of 5, the T2 agent must reduce the MRI signal by a factor of 1.25% 
relative to the background:
(A8)
The relaxation rate produced by a contrast agent can be approximated by the following 
equation:
(A9)
Substituting the value of R2,CA from Eq. (9) in Eq. (8), we arrive at the following expression 
for contrast agent concentration:
(A10)
To calculate the optimal TE, we use Eq. (11), which evaluates the TE that maximizes signal 
relative to background:
(A11)
Eq. (10) and (11) can be solved analytically to evaluate xCA which is the minimum 
concentration of the T2 agent needed to produce a 1.25% signal change using an optimal TE 
time.
Concentration of CEST agent needed to achieve a CNR of 5
Steady state proton transfer ratio for a CEST agent can be described using the following 
equation [35]:
(A12)
The minimum concentration of a CEST reporter required to achieve a signal change of 
1.25% can be calculated directly from the above equation.
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Glossary
ADC Apparent Diffusion Coefficient
AQP1 Aquaporin 1
BOLD Blood Oxygenation Level Dependent
CEST Chemical Exchange Saturation Transfer
CGRP Calcitonin Gene Related Peptide
CNR Contrast-to-Noise Ratio
DNP Dynamic Nuclear Polarization
DWI Diffusion Weighted Imaging
FEXI Filter Exchange Imaging
FRET Förster Resonance Energy Transfer
GV Gas Vesicle
HyperCESTHyperpolarized Chemical Exchange Saturation Transfer
MPI Magnetic Particle Imaging
MRET Magnetic Resonance Energy Transfer
MRI Magnetic Resonance Imaging
ParaCEST Paramagnetic Chemical Exchange Saturation Transfer
PHIP Parahydrogen Induced Polarization
SNR Signal-to-Noise Ratio
UT-B Urea Transporter
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Highlights
• Biomolecular reporters are essential to enable MR imaging of cellular 
function
• Several breakthrough concepts in biomolecular MRI reporters were recently 
developed
• Water channel proteins serve as reporter genes for diffusion-weighted imaging
• Gas-filled proteins produce contrast in hyperpolarized 129Xe MRI
• Peptides altering blood flow produce locally enhanced hemodynamic contrast
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Figure 1. Mechanisms of Biomolecular MRI Contrast
(a) T1 reporters include proteins containing paramagnetic metal ions such as iron or 
manganese. (b) T2 reporters include proteins biomineralizing iron oxide nanoparticles. (c) 
CEST reporters include proteins with large numbers of exchangeable protons. (d) 
Accumulation and activation-based reporters transport, trap or catalytically activate 
exogenous contrast agents. (e) Diffusion based reporters are proteins that facilitate the 
exchange of water across the cell membrane. (f) HyperCEST reporters contain chemically 
distinct binding sites for xenon. (g) Hemodynamic reporters act on the vasculature to 
increase local blood flow.
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Figure 2. Diffusion-based Reporters
(a) Diffusion weighted images of mammalian cells expressing AQP1 and GFP (negative 
control) acquired using Δeff = 298 ms and b-values of 2089 s/mm2 (CHO), 1000 s/mm2 
(U87), and 800 s/mm2 (N2a) (b) Left: Experimental approach for establishing bilateral 
tumor xenografts, inducing transgene expression with doxycycline (dox), and acquiring 
diffusion-weighted images. Right: Representative diffusion weighted image of a horizontal 
section of the mouse brain 48 hours after dox injection. Inset shows a diffusion weighted 
image of the same mouse brain prior to dox induction. Images were acquired using Δeff = 98 
ms and b = 1000 s/mm2 (c) Monte Carlo simulations of water diffusion in cells show an 
increase in apparent diffusion coefficient (ADC) with increasing cell membrane permeability 
and at long diffusion times (Δeff) that is achieved using stimulated echo DWI (d) Increase in 
ADC in CHO, U87, and N2a cells relative to control cells expressing GFP, measured at Δeff 
= 398 ms. Adapted with permission from [56].
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Figure 3. HyperCEST Reporters
(a) Diagram of a gas vesicle: a hollow gas-containing nano-compartment (solid shading) 
surrounded by a gas-permeable protein shell (ribbed shading). (b) Transmission electron 
micrographs of individual GVs purified from Halobacterium NRC-1 in their intact (left) and 
collapsed (right) state. (c) Diagram of 129Xe chemical exchange saturation transfer between 
bulk aqueous solvent (left) and GVs (hexagons) either in isolation or inside a cell (gray). (d) 
Frequency-dependent saturation spectra for intact (red) and collapsed (black) GVs. (e) 
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Saturation contrast image of a three-compartment phantom containing 400pM GVs, 100pM 
GVs and buffer. Adapted with permission from [92, 113].
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Table 1
Mechanisms of Biomolecular MRI Contrast
Mechanism Example Approximate
Detection Limit
Advantages Disadvantages
T1 P450-BM3 [9]
14 µM Readily engineered as 
molecular sensors Metal requirement700 µg/mL
T2 Ferritin [25, 26, 114–116]
84 nM
Relatively sensitive
Metal requirement
40 µg/mL Background T2 contrast
CEST LRP [33]
2.5 µM
No metal requirement
Background CEST from proteins 
in tissue
81 µg/mL
(assuming no 
background 
CEST)
Multiplexing
Accumulation & Activation TIMD2 [46] Unknown Sensitivity due to 
amplification
Requires exogenous contrast 
agent
Pharmacokinetically limited
Diffusion AQP1 [56]
500 nM No metal requirement
High background in some tissues
14 µg/mL Autologous
HyperCEST Gas Vesicles [92]
10 pM Molar sensitivity due to hyperpolarization Requires hyperpolarized xenon 
delivery
4 µg/mL Multiplexing
Hemodynamics CGRP [101]
10 nM Sensitivity due to 
amplification Background contrast and 
unknown long-term effects
53 ng/mL Potentially fast kinetics
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Table 2
List of variables
S. No. Variable Definition
1 Sbkgr Background MRI signal in the absence of contrast agent
2 SCA MRI signal in the presence of a contrast agent
3 R1,CA T1 relaxation rate in the presence of contrast agent
4 TR, TR,opt Repetition time, optimal repetition time
5 xCA Concentration of T1, T2, or CEST agent
6 R2,CA T2 relaxation rate in the presence of contrast agent
7 TE,TE,opt Echo time, optimal echo time
8 PTR Proton transfer ratio
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Table 3
List of assumed parameters
S. No. Variable Definition Value
1 R1,bkgr Background T1 relaxation rate in the absence of contrast agent 0.67 s−1
2 rCA T1 or T2 relaxivity of contrast agent 1 mM−1 s−1 (T1) 3000 mM−1 s−1 (T2)
3 R2,bkgr Background T2 relaxation rate in the absence of contrast agent 20 s−1
4 xH2O Concentration of water in tissues 38.5 M
5 nCA Number of exchangeable protons in CEST agent 200
6 α Saturation efficiency in CEST imaging 1
7 kCA→w Exchange rate of protons from CEST agent to bulk water 1 kHz
8 T1 Longitudinal relaxation time of water 1.5 s
9 tsat CEST saturation time 1.5 s
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